Clinical trials
Phase 1 Wounds and Injuries trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Unknown status | 7 |
| Terminated | 5 |
| Recruiting | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London Health Sciences Centre | 2 |
| Andrew Tomas Reisner | 1 |
| Antonia New | 1 |
| Arteriocyte, Inc. | 1 |
| Arun Aneja | 1 |
| Assiut University | 1 |
| Avraham Katzir | 1 |
| Beirut Arab University | 1 |
| Brigham and Women's Hospital | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wounds and Injuries | 52 |
| Stress Disorders, Post-Traumatic | 6 |
| Burns | 2 |
| Cicatrix | 2 |
| Color Vision Defects | 2 |
| Diabetic Foot | 2 |
| Pain | 2 |
| Spinal Cord Injuries | 2 |
| Trauma, Nervous System | 2 |
| Acute Lung Injury | 1 |
Trials
Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.